Evidence map›Paper›PMID 34767629›Full record

ArticleCancer2022

Resilient health care in global pediatric oncology during the COVID-19 pandemic.

Dylan E Graetz, Elizabeth Sniderman, Cesar A Villegas, Erica C Kaye, Iman Ragab, Aliaksandra Laptsevich, Biemba Maliti, Gita Naidu, Haiying Huang, Pascale Y Gassant and 14 more

Abstract read
In one paragraph

Article in Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Mistletoe in Cancer Cell Biology: Recent Advances.Current issues in molecular biology · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Dylan E GraetzSt. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-4541-6910
Elizabeth SnidermanSt. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0001-6004-6068
Cesar A VillegasSt. Jude Children's Research Hospital, Memphis, Tennessee.
Erica C KayeSt. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-6522-3876
Iman RagabHematology-Oncology Unit, Ain Shams University, Children's Hospital, Cairo, Egypt.
Aliaksandra LaptsevichBelarusian Research Center for Pediatric Oncology Hematology and Immunology, Minsk, Belarus.
Biemba MalitiCancer Diseases Hospital, Lusaka, Zambia.
Gita NaiduChris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa.
Haiying HuangGuangzhou Women and Children's Medical Center, Guangzhou, China.
Pascale Y GassantHospital Saint-Damien, Port-au-Prince, Haiti.
Luciana Nunes SilvaHospital Martagao Gesteira, Salvador, Brazil.
Daniela ArceHospital Pediatrico de Sinaloa, Culiacan, Mexico.
Jacqueline Montoya VasquezInstituto Nacional de Enfermedades Neoplasicas, Lima, Peru.
Ramandeep Singh AroraMax Super Specialty Hospital, New Delhi, India.ORCID 0000-0002-2613-4539
Ana Patricia AlcasabasUniversity of the Philippines, Philippine General Hospital, Manila, Philippines.
Desy RusmawatiningtyasSardjito General Hospital, Yogyakarta, Indonesia.
Muhammad Rafie RazaThe Indus Hospital, Karachi, Pakistan.
Pablo VelascoPediatric Oncology and Hematology Department, Vall d'Hebron Hospital, Barcelona, Spain.
Joyce KambuguUganda Cancer Institute, Kampala, Uganda.
Anna VinitskySt. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0003-4160-2633
Carlos Rodriguez-GalindoSt. Jude Children's Research Hospital, Memphis, Tennessee.
Asya AgulnikSt. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0001-8932-8181
Daniel C MoreiraSt. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0003-4082-156X
COVIMPACT Study Group

Funding

American Lebanese Syrian Associated Charities
6 · The paper itself

Abstract

backgroundIn the face of unprecedented challenges because of coronavirus disease 2019, interdisciplinary pediatric oncology teams have developed strategies to continue providing high-quality cancer care. This study explored factors contributing to health care resilience as perceived by childhood cancer providers in all resource level settings.

methodsThis qualitative study consisted of 19 focus groups conducted in 16 countries in 8 languages. Seven factors have been previously defined as important for resilient health care including: 1) in situ practical experience, 2) system design, 3) exposure to diverse views on the patient's situation, 4) protocols and checklists, 5) teamwork, 6) workarounds, and 7) trade-offs. Rapid turn-around analysis focused on these factors.

resultsAll factors of health care resilience were relevant to groups representing all resource settings. Focus group participants emphasized the importance of teamwork and a flexible and coordinated approach to care. Participants described collaboration within and among institutions, as well as partnerships with governmental, private, and nonprofit organizations. Hierarchies were advantageous to decision-making and information dissemination. Clinicians were inspired by their patients and explained creative trade-offs and workarounds used to maintain high-quality care.

conclusionsFactors previously described as contributing to resilient health care manifested differently in each institution but were described in all resource settings. These insights can guide pediatric oncology teams worldwide as they provide cancer care during the next phases of the pandemic. Understanding these elements of resilience will also help providers respond to inevitable future stressors on health care systems.

Indexed as

COVID-19NeoplasmsChildDelivery of Health CareHumansPandemicsSARS-CoV-2COVID-19globalpediatric oncologyqualitative research

Identifiers

PMID34767629
PMCPMC8653316

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.